Search results for "Ih"

showing 10 items of 9382 documents

Effects of HRV-Guided vs. Predetermined Block Training on Performance, HRV and Serum Hormones

2017

AbstractThe aim of this study was to compare heart rate variability -guided (HRVG) and predetermined (PD) block periodization of high intensity aerobic training (HIT). Endurance performance, neuromuscular performance, heart rate variability (HRV) and serum hormone concentrations were measured before, in the middle and after the 8-week training period in 24 endurance trained males. Both groups improved significantly maximal treadmill velocity (Vmax) (p<0.001) and 3000 m running performance (HRVG; p<0.001 and PD; p=0.001). The relative changes in Vmax and countermovement jump were significantly greater in HRVG (p<0.05). Nocturnal heart rate decreased in both groups (p<0.01), but H…

AdultMalemedicine.medical_specialtyHydrocortisoneblock periodizationPhysical Therapy Sports Therapy and RehabilitationAthletic PerformanceHigh-Intensity Interval Training030204 cardiovascular system & hematologyInterval trainingYoung Adult03 medical and health sciences0302 clinical medicineHeart RateInternal medicineautonominen hermostoHeart ratemedicineHumansAerobic exerciseHeart rate variabilityTestosteroneOrthopedics and Sports MedicineMuscle StrengthTreadmillMuscle SkeletalHydrocortisoneAnthropometrybusiness.industryheart rate variability030229 sport sciencesintervalliharjoitteluAutonomic nervous systemrunning performancePhysical EnduranceCardiologyPhysical therapybusinessVO2maxHigh-intensity interval trainingmedicine.drugInternational Journal of Sports Medicine
researchProduct

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis:A Randomized, Placebo-Controlled, Phase II Study

2017

Objective To determine the effect of selexipag, an oral, selective IP prostacyclin receptor agonist, on the frequency of attacks of Raynaud's phenomenon (RP) in patients with systemic sclerosis (SSc). Methods Patients with SSc-related RP were randomized 1:1 to placebo (n = 38) or selexipag (n = 36) in individualized doses (maximum of 1,600 μg twice daily) during a 3-week titration period. The primary end point was the weekly average number of RP attacks during the study maintenance period, analyzed using a Bayesian approach with a negative binomial model adjusted for baseline number of RP attacks. Other outcome measures included Raynaud's Condition Score (RCS), RP attack duration, and treat…

AdultMalemedicine.medical_specialtyImmunologyPhases of clinical researchSelexipagPlaceboSeverity of Illness Indexlaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodRheumatologyRandomized controlled triallawInternal medicineAcetamidesSeverity of illnessClinical endpointHumansImmunology and AllergyMedicine030212 general & internal medicineAdverse effectAntihypertensive Agents030203 arthritis & rheumatologyScleroderma Systemicbusiness.industryBayes TheoremRaynaud DiseaseMiddle AgedClinical trialTreatment OutcomechemistryPyrazinesFemalebusiness
researchProduct

Assessment and diagnosis of suspected glaucoma in patients with mucopolysaccharidosis

2015

Purpose The mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders, characterized by the accumulation of glycosaminoglycans within multiple organ systems including the eye. This study aimed to determine the prevalence of glaucoma in patients with MPS, as well as the characteristics, diagnosis and management of patients with MPS and glaucoma. Methods A multicentre retrospective case-note review was carried out by ophthalmologists from four tertiary referral centres to identify patients with MPS who had been treated for glaucoma. Clinical ophthalmological data were collected using standardized data collection forms. Results Fourteen patients were identified (27 eyes) of 2…

AdultMalemedicine.medical_specialtyIntraocular pressureAdolescentgenetic structuresMucopolysaccharidosisOptic DiskAge at diagnosisGlaucomaTrabeculectomyTertiary Care CentersYoung AdultOphthalmologyPrevalenceHumansMedicineIn patientChildAntihypertensive AgentsIntraocular PressureOrgan systemIridocorneal angleRetrospective Studiesbusiness.industryAustraliaMalaysiaInfantGeneral MedicineMucopolysaccharidosesmedicine.diseaseeye diseasesEuropeOphthalmologymedicine.anatomical_structureChild PreschoolFemaleOcular Hypertensionsense organsVisual FieldsbusinessOptic discActa Ophthalmologica
researchProduct

Effect of dual blockade of renin–angiotensin system on TGFβ1 and left ventricular structure and function in hypertensive patients

2007

The effects of 24 weeks losartan and ramipril treatment, both alone and in combination, on left ventricular mass (LVM), circulating transforming growth factor beta1 (TGFbeta1), procollagen type I (PIP) and III (PIIIP), have been evaluated in hypertensive (HT) patients. A total of 57 HT with stage 1 and 2 essential hypertension were included. After 4 weeks run in, a randomized double-blind, three arms, double dummy, independent trial was used. All HT patients were randomly allocated to three treatment arms consisting of losartan (50 mg/daily), ramipril (5 mg/ daily) and combined (losartan 50 mg/daily + ramipril 5 mg/daily) for 24 weeks. TGFbeta1, PIP and PIIIP, LVM, LVM/h(2.7) and other echo…

AdultMalemedicine.medical_specialtyLeft ventricular structureHeart VentriclesBlood PressureEnzyme-Linked Immunosorbent AssayAngiotensin II Receptor BlockersPeptide hormoneSeverity of Illness IndexDual blockadeCollagen Type ILosartanVentricular Function LeftRenin-Angiotensin SystemTransforming Growth Factor beta1Double-Blind MethodRamiprilInternal medicineRenin–angiotensin systemPrevalenceInternal MedicineHumansMedicineAntihypertensive AgentsUltrasonographyAnalysis of Variancebusiness.industryMiddle AgedAngiotensin IICollagen Type IIITreatment OutcomeEndocrinologyItalyHypertensionACE inhibitorDrug Therapy CombinationFemaleHypertrophy Left VentricularbusinessBiomarkersmedicine.drugJournal of Human Hypertension
researchProduct

Associations between long-term physical activity, waist circumference and weight gain: a 30-year longitudinal twin study.

2007

Background and objective: Physical activity level and obesity are both partly determined by genes and childhood environment. To determine the associations between long-term leisure-time physical activity, weight gain and waist circumference and whether these are independent of genes and childhood effects. Design and subjects: The study design is a 30-year follow-up twin study in Finland. For this study, 146 twin pairs were comprehensively identified from the large Finnish Twin Cohort. These twin pairs were discordant for both intensity and volume of leisure physical activity in 1975 and 1981 and were healthy in 1981. At follow-up in 2005, both members of 89 pairs were alive and participated…

AdultMalemedicine.medical_specialtyLongitudinal studyWaistAdolescentEndocrinology Diabetes and MetabolismDizygotic twinHealth BehaviorMedicine (miscellaneous)physical activity030209 endocrinology & metabolismMotor ActivityliikuntaWeight Gain03 medical and health sciences0302 clinical medicineInternal medicineTwins DizygoticmedicineBody SizeHumansObesity030212 general & internal medicineExerciseFinlandNutrition and Dieteticsbusiness.industryTwins MonozygoticMiddle AgedCircumferenceTwin studyPhysical activity levelEndocrinologylihavuusFemalemedicine.symptomEpidemiologic MethodsbusinessWeight gainBody mass indexDemography
researchProduct

Arterial Destiffening in Previously Untreated Mild Hypertensives After 1 Year of Routine Clinical Management

2016

BACKGROUND Arterial stiffness, measured with pulse wave velocity (PWV), is now classified as a marker of target organ damage (TOD) alongside left ventricular hypertrophy and moderately increased albuminuria. Interventional studies on treated hypertensive patients have shown that PWV could be improved. Our aim was to assess changes in arterial stiffness after 1 year of routine clinical practice in never-treated hypertensive patients. PATIENTS AND METHODS We studied 356 never-treated patients with suspected hypertension. After standard clinical assessment during which presence of TOD was evaluated, hypertension diagnosis was confirmed in 231 subjects who subsequently received standard routine…

AdultMalemedicine.medical_specialtyMean arterial pressureTime FactorsVasodilationPulse Wave Analysis030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVascular Stiffness0302 clinical medicineInternal medicineHeart ratePrevalenceInternal MedicineHumansMedicineArterial Pressure030212 general & internal medicinePulse wave velocityAntihypertensive Agentsbusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeBlood pressureSpainCase-Control StudiesHypertensionAlbuminuriaArterial stiffnessCardiologyDrug Therapy CombinationFemalemedicine.symptombusinessAmerican Journal of Hypertension
researchProduct

The ipsilateral corticospinal responses to cross-education are dependent upon the motor-training intervention

2018

This study aimed to identify the ipsilateral corticospinal responses of the contralateral limb following different types of unilateral motor-training. Three groups performing unilateral slow-paced strength training (SPST), non-paced strength training (NPST) or visuomotor skill training (VT) were compared to a control group. It was hypothesised that 4 weeks of unilateral SPST and VT, but not NPST, would increase ipsilateral corticospinal excitability (CSE) and reduce short-interval cortical inhibition (SICI), resulting in greater performance gains of the untrained limb. Tracking error of the untrained limb reduced by 29 and 41% following 2 and 4 weeks of VT. Strength of the untrained limb in…

AdultMalemedicine.medical_specialtyNeurologyStrength trainingTransfer Psychologymedicine.medical_treatmentPyramidal Tractsneurofysiologiacross-educationcorticospinalElectromyographyPhysical strengthFunctional LateralityCross educationYoung Adult03 medical and health sciencesSkills training0302 clinical medicinePhysical medicine and rehabilitationHumansMedicineMuscle StrengthMuscle Skeletalstrength-trainingmotoriset taidotPyramidal tractsmedicine.diagnostic_testElectromyographybusiness.industryGeneral NeuroscienceResistance Training030229 sport sciencesEvoked Potentials MotorTranscranial Magnetic StimulationTranscranial magnetic stimulationhermo-lihastoimintamedicine.anatomical_structureFemalevoimaharjoittelubusinessskill-trainingPsychomotor Performancecortical inhibition030217 neurology & neurosurgeryExperimental Brain Research
researchProduct

Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

2002

The objective of the study was to assess the factors related to the occurrence of microalbuminuria during the follow-up of a young adult group with essential hypertension that had not been previously treated. Normo-albuminuric essential hypertensives, <50 years old, who had not been previously treated with antihypertensive drugs and who did not have diabetes mellitus were included. After the initial evaluation, patients were treated using only nonpharmacological measures (n=62), β-blockers (n=38), ACE inhibitors (n=64), calcium channel blockers (n=8), and several classes (n=15). Measurements were taken for office blood pressure, biochemical profile, and 24-hour urinary albumin excretion…

AdultMalemedicine.medical_specialtyNifedipineAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsEssential hypertensionEnalaprilLisinoprilRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaBisoprololHumansYoung adultAntihypertensive AgentsProportional Hazards ModelsProteinuriabusiness.industryFollow up studiesMiddle AgedCalcium Channel Blockersmedicine.diseaseTreatment OutcomeEndocrinologyBlood pressureAtenololHypertensionAlbuminuriaRegression AnalysisFemaleMicroalbuminuriamedicine.symptombusinessPreviously treatedHypertension
researchProduct

Elevated [18F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease

2010

Udgivelsesdato: 2010-Feb-15 PET studies with the DOPA decarboxylase substrate 6-[(18)F]fluoro-l-DOPA (FDOPA) reveal the storage of [(18)F]-fluorodopamine within synaptic vesicles, mainly of dopamine fibres. As such, FDOPA PET is a sensitive indicator of the integrity of the nigrostriatal dopamine innervation. Nonetheless, there have been several reports of focal elevations of FDOPA utilization in brain of patients with Parkinson's disease (PD), all based on reference tissue methods. To investigate this phenomenon further, we used voxel-wise steady-state kinetic analysis to search for regions of elevated FDOPA utilization (K; ml g(-1) min(-1)) and steady-state trapping (V(d); ml g(-1)) in a …

AdultMalemedicine.medical_specialtyParkinson's diseaseMetabolic Clearance RateCognitive NeuroscienceStriatumNucleus accumbensPeriaqueductal grayNucleus AccumbensDopamineInternal medicinemedicineHumansPeriaqueductal GrayAgedAromatic L-amino acid decarboxylasebusiness.industryParkinsonismPutamenParkinson DiseaseMiddle Agedmedicine.diseaseDihydroxyphenylalanineEndocrinologyNeurologyPositron-Emission TomographyFemaleRadiopharmaceuticalsbusinessNeurosciencemedicine.drugNeuroImage
researchProduct

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.

2006

The objective of the present study was to assess factors related to long-term changes in urinary albumin excretion (UAE) of nondiabetic microalbuminuric (n = 252) or proteinuric hypertensive individuals (n = 58) in a prospective follow-up.After enrollment, patients were placed on usual care including nonpharmacological treatment and/or treatment with an antihypertensive drug regime to achieve blood pressure135/85 mmHg. Periodic UAE measurements were performed until regression or significant reduction (defined when UAE dropped50% from the initial values, plus reduction of UAE to30 mg/24 h for microalbuminuric patients and300 mg/24 h for proteinuric patients).Among the microalbuminuric patien…

AdultMalemedicine.medical_specialtyPhysiologymedicine.drug_classAdrenergic beta-AntagonistsUrologyRenal functionAngiotensin-Converting Enzyme InhibitorsBlood PressureEssential hypertensionExcretionInternal medicineInternal MedicinemedicineAlbuminuriaHumansAntihypertensive drugbusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseCalcium Channel BlockersConfidence intervalEndocrinologyBlood pressureHypertensionFemaleCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor BlockersFollow-Up StudiesGlomerular Filtration RateJournal of hypertension
researchProduct